Your browser doesn't support javascript.
loading
Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study.
Badar, Talha; Narra, Ravi; Mims, Alice S; Heckman, Michael G; Shallis, Rory M; Fahad, Sheikh; Hunter, Cameron; Kota, Vamsi; Othman, Tamer Adel; Jonas, Brian; Desai, Shreya; de Camargo Correia, Guilherme Sacchi; Patel, Anand; DuVall, Adam S; Palmisiano, Neil; Curran, Emily; Omer, Zulfa; Advani, Anjali; Atallah, Ehab; Litzow, Mark.
Affiliation
  • Badar T; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA.
  • Narra R; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Mims AS; Division of Hematology and Oncology, Ohio State University, Columbus, Ohio, USA.
  • Heckman MG; Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, Florida, USA.
  • Shallis RM; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Fahad S; Division of Clinical Trials and Biostatistics, Mayo Clinic, Jacksonville, Florida, USA.
  • Hunter C; Section of Hematology, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.
  • Kota V; Division of Hematology and Oncology, Georgia Cancer Center, Augusta, Georgia, USA.
  • Othman TA; Division of Hematology and Oncology, University of California-Davis, Davis, California, USA.
  • Jonas B; Division of Hematology and Oncology, University of California-Davis, Davis, California, USA.
  • Desai S; Division of Hematology and Oncology, Georgia Cancer Center, Augusta, Georgia, USA.
  • de Camargo Correia GS; Division of Hematology-Oncology and Blood and Marrow Transplantation and Cellular Therapy Program, Mayo Clinic, Jacksonville, Florida, USA.
  • Patel A; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • DuVall AS; Section of Hematology and Oncology, Department of Medicine, University of Chicago, Chicago, Illinois, USA.
  • Palmisiano N; Rutgers Cancer Institute of New Jersey, Rutgers University, New Brunswick, New Jersey, USA.
  • Curran E; Department of Medicine, Division of Hematology and Oncology University of Cincinnati, Cincinnati, Ohio, USA.
  • Omer Z; Department of Medicine, Division of Hematology and Oncology University of Cincinnati, Cincinnati, Ohio, USA.
  • Advani A; Division of Hematology, Cleveland Clinic, Cleveland, Ohio, USA.
  • Atallah E; Division of Hematology and Medical Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
  • Litzow M; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 2024 Sep 10.
Article in En | MEDLINE | ID: mdl-39253997
ABSTRACT
Intensive chemotherapy (IC) combination with second- or third-generation TKI improves survival compared to non-IC with first-generation TKI. Allo-HCT was suggestive of improving RFS/OS after propensity score matching and multivariable analysis.
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Hematol Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Am J Hematol Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States